6533b856fe1ef96bd12b27e6

RESEARCH PRODUCT

Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register

Magdalena Okarska-napierałaKamila M. LudwikowskaLeszek SzenbornNatalia DudekAnna ManiaPiotr BudaJanusz KsiążykKatarzyna Mazur-malewskaMagdalena FiglerowiczMaciej SzczukockiBeata KucińskaBożena WernerLidia StopyraAgnieszka CzechElżbieta Berdej-szczotAneta GawlikPaulina OpalińskaArtur MazurDanuta Januszkiewicz-lewandowskaCezary NiszczotaTeresa JackowskaJacek WysockiMois Cor Study GroupErnest Kuchar

subject

Pediatricsmedicine.medical_specialtyPIMS; MIS-C; SARS-CoV-2; COVID-19; Kawasaki disease; surveyCoronavirus disease 2019 (COVID-19)lcsh:MedicineProspective dataMIS-CContext (language use)Disease030204 cardiovascular system & hematologyNationwide surveyArticle03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesPandemicmedicinesurvey030212 general & internal medicinePIMSKawasaki diseaseSARS-CoV-2business.industrylcsh:RCOVID-19General Medicinemedicine.diseaseKawasaki diseaseDifferential diagnosisbusiness

description

Pediatric inflammatory multisystem syndrome (PIMS) is a new entity in children, likely associated with previous coronavirus disease 19 (COVID-19) infection. Most of the reports about PIMS come from countries particularly hit by the COVID-19 pandemic. Our aim was to investigate the nature of inflammatory syndromes in Poland (country with low COVID-19 prevalence) and to perceive the emergence of PIMS in our country. On 25 May 2020, we launched a nationwide survey of inflammatory syndromes in children for retrospective (since 4 March 2020) and prospective data collection. Up to 28 July, 39 reported children met the inclusion criteria. We stratified them according to age (&lt

yearjournalcountryeditionlanguage
2020-10-01Journal of Clinical Medicine
https://doi.org/10.3390/jcm9113386